ZAYREE
DEAD

Serial Number

97591749

Owner

DAY ONE BIOPHARMACEUTICALS, INC.

Attorney

Connie L. Ellerbach

Filing Date

Sep 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ZAYREE Trademark

Serial Number: 97591749

ZAYREE is a trademark filed by DAY ONE BIOPHARMACEUTICALS, INC. on September 14, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

DAY ONE BIOPHARMACEUTICALS, INC. (17 trademarks)

1800 Sierra Point Parkway, Suite 200
Brisbane, CA 94005

Entity Type: 03

Trademark Details

Filing Date

September 14, 2022

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations; pharmaceutical preparations for human use; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; targeted medical preparations for use in the field of cancer prevention and treatment; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Medical information services; healthcare services; research, development, and evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; design, development, research, and testing of drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical information services, namely, providing information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 26, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 26, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 26, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 10, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 10, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 10, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 7, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2022 NWOS
NEW APPLICATION ENTERED
Sep 17, 2022 NWAP